[Effect and toxicity on the combined use of pyrazinamide, ethionamide and kanamycin in the retreatment of pulmonary tuberculosis (author's transl)].
D000293:Adolescent; D000328:Adult; D000995:Antitubercular Agents / Q000633:toxicity; D004359:Drug Therapy, Combination; D005000:Ethionamide / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007612:Kanamycin / Q000008:administration & dosage*; D008297:Male; D011718:Pyrazinamide / Q000008:administration & dosage*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000995:Antitubercular Agents; D011718:Pyrazinamide; D007612:Kanamycin; D005000:Ethionamide